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LensIn addition to their key role as structural lens proteins, α-crystallins also appear to confer protection against
many eye diseases, including cataract, retinitis pigmentosa, and macular degeneration. Exogenous recombinant
α-crystallin proteins were examined for their ability to prevent cell death induced by heat or oxidative stress
in a human lens epithelial cell line (HLE-B3). Wild type αA- or αB-crystallin (WT-αA and WT-αB) and αA- or
αB-crystallins, modiﬁed by the addition of a cell penetration peptide (CPP) designed to enhance the uptake of
proteins into cells (gC-αB, TAT-αB, gC-αA), were produced by recombinant methods. In vitro chaperone-like
assays were used to assay the ability of α-crystallins to protect client proteins from chemical or heat induced
aggregation. In vivo viability assays were performed in HLE-B3 to determine whether pre-treatment
with α-crystallins reduced death after exposure to oxidative or heat stress. Most of the ﬁve recombinant
α-crystallin proteins tested conferred some in vitro protection fromprotein aggregation,with the greatest effect
seen with WT-αB and gC-αB. All α-crystallins displayed signiﬁcant protection to oxidative stress induced cell
death, while only the αB-crystallins reduced cell death induced by thermal stress. Our ﬁndings indicate that
the addition of the gC tag enhanced the protective effect of αB-crystallin against oxidative but not thermally-
induced cell death. In conclusion, modiﬁcations that increase the uptake of α-crystallin proteins into cells,
without destroying their chaperone-like activity and anti-apoptotic functions, create the potential to use these
proteins therapeutically.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
α-Crystallinsmake up themajor protein component of themamma-
lian lens and function as structural and refractive proteins [1,2]. The two
forms of α-crystallin (αA-crystallin and αB-crystallin) share 57%
sequence homology [3] and have been reported to form multimeric
complexeswith each other at a ratio of 3:1 (αB-crystallin:αB-crystallin)
[4]. More recent studies suggest thatαA- andαB-crystallin are found in
distinct membrane compartments within cells [5] and may therefore
have additional functions in addition to acting as refractive proteins.
These additional functions may differ between each isoform, since αA-
crystallin is found almost exclusively in the lens while αB-crystallin is
found in multiple tissues including the retina, heart, skeletal muscle,
glia, kidney, lung, and Schwann cells [6–9].
In vitro studies of α-crystallins indicated that the proteins function as
molecular chaperones basedon their ability to promote refolding after de-
naturation and suppress thermally-induced protein aggregation [10,11].
Additionally, transfection ofα-crystallin DNA into cultured cells has indi-
cated its ability to promote cellular thermo-resistance and prevent UVA-logy, University of Colorado
top 8311, Aurora, CO 80045.
ueller).
ights reserved.induced apoptosis in human lens epithelial cells [12–14]. Furthermore,
α-crystallin knockout animal models have decreased resistance against
oxidative stress [15]. αB-crystallin has been shown to be up-regulated
in cells exposed to heat, osmotic, and mechanical stresses, likely
preventing damage induced apoptosis [16–18]. In human lens and retina
cells under oxidative stress, αB-crystallin protects mitochondrial cyto-
chrome c from oxidation, preventing apoptosis [19].
We hypothesize that the introduction of α-crystallins to the lens
may represent an approach to limit cell death, and progression of
cataract. Epithelial cells that progress to cortical ﬁber cells accumulate
large amounts of proteins that must maintain structural integrity for
many decades to support lens transparency. Over time, these cells lose
the capacity to produce new proteins [1]. It has been hypothesized
that in response to metabolic and environmental stresses to the lens,
(UV light exposure, oxidative stress secondary to metabolic diseases),
α-crystallin binds to both unfolded proteins and those involved in
apoptosis, including cytochrome c and caspase 3, to prevent cell death
[19–22]. Therefore, increased levels ofα-crystallinmay delay or prevent
cataract.
While delivery of recombinant α-crystallins to tissues offers an
intriguing approach to prevent protein aggregation diseases, protein
uptake into cells at levels sufﬁcient for efﬁcacy is likely to be a challenge.
A peptide in the TATprotein of human immunodeﬁciency virus-1 (HIV-1)
was the ﬁrst cell penetration peptide (CPP) shown to enter cells non-
selectively and without a speciﬁc receptor [23]. In 1994, the TAT CPP
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chemically cross-linked part of TAT to proteins which resulted in trans-
duction of otherwise impermeable proteins [24]. Similarly, herpes
simplex virus type 1 (HSV) encodes for the glycoprotein C (gC) shown
to be involved in viral attachment to cells. We have previously shown
that the fusion of either TAT or gC CPP to αB-crystallin led to a signiﬁ-
cant increase in uptake of α-crystallin to lens-derived cells in culture
after a one hour incubation [25]. However, the ability of these proteins
to function within these cells is currently unknown. The purpose of
the present study was to assess the efﬁcacy of α-crystallins introduced
in this manner against various types of stress in a cell culture model.
2. Methods
2.1. Cell culture
Human lens epithelial cells (HLE-B3) [26] were grown in DMEM
(Sigma, St. Louis, MO) with 20% fetal bovine serum (SAFC Biosciences,
Lenexa, KS) and penicillin–streptomycin–amphotericin B (10 units/
ml–10 units/ml–0.25 μg/ml (HyClone, Logan, UT)) at 37 °C in the
presence of 5% CO2. Cells were added to 12-well or 96-well plates
(Costar, Corning, NY) and allowed to adhere overnight.
2.2. Cloning of recombinant human αA-crystallin fused with gC cell
penetration peptide (CPP)
Construction of αA-crystallin with an N-terminal gC peptide was
carried out as previously reported for gC-fusedαB-crystallin [25]. Brief-
ly, primers for the gC CPP were designed with NcoI (5′ forward primer)
and HindIII (3′ reverse primer) sequences and were obtained from IDT
(Coralville, IA). PCR was carried out using these primers together with
our previously-described αA-crystallin expression construct [27] to
prepare gC-αA coding region with the CPP at the N-terminus of αA.
PCR was performed for 30 cycles of 95 °C, 50 °C, and 72 °C for 1 min
each. Reaction products were separated on a 1% agarose operated in
Tris–acetate EDTA (TAE) buffer. PCR bands of the expected size were
excised from the gel and puriﬁed using the quick spin kit (Qiagen,
Germantown, MD) following the manufacturer's protocol. Puriﬁed
PCR DNA along with pET-23d vector DNA was digested with NcoI and
HindIII (New England Biolabs, Ipswich, MA). Restriction fragments
were resolved by 1% agarose TAE gel. Puriﬁed vector DNA and PCR am-
pliﬁed DNAwere ligated using a quick ligase kit (NEB) and transformed
into Escherichia coli strain TOP 10 (Life Technologies, Carlsbad, CA).
Colonies were selected and inserts conﬁrmed by DNA sequencing.
2.3. Production of recombinant α-crystallin proteins
Preparation of expression plasmids encoding wild-type αA-crystallin
(WT-αA), wild-type αB-crystallin (WT-αB), gC-tagged αA-crystallin
(gC-αA), gC-tagged αB-crystallin (gC-αB), and TAT-tagged αB-crystallin
(TAT-αB) have previously been reported [25,27,28]. Expression and
puriﬁcation of recombinant crystallins were carried out as described
[28]. Puriﬁed proteins were kept at 4 °C if used immediately, or were
stored at−80 °C.
2.4. Cellular heat stress assay
HLE-B3 cells grown to ~90% conﬂuence were treated with a single
α-crystallin for 1 h at 37 °C. Brieﬂy, 12.5 μg/ml of α-crystallins (or PBS
alone as a vehicle control) was added to the culture medium and cells
were incubated for 1 h at 37 °C. The culture mediumwas then replaced
with fresh culture media without α-crystallin. After this media
exchange, cells were placed at 45 °C for 1 h to induce heat stress.
Following the 45 °C heat treatment, cells were returned to 37 °C.
Live cells were identiﬁed 23 h later using the Live/Dead Viability/
Cytotoxicity Assay Kit (Life Technologies) which relies on cytoplasmicesterases to cleave calcein and generate intracellular ﬂuorescence
(calcein assay). To measure this activity, 23 h after heat treatment,
cells were washed twice with PBS and placed in 120 μL PBS with 5 μM
Calcein AM and incubated for 20 min at 25 °C in the dark. Following in-
cubation, viable cells were detected using an excitation at 485 nm and
emission at 528 nm with a Synergy 4 Multi-mode Microplate Reader
andGen5Reader Control andData Analysis Software (BioTek,Winooski,
VT). After subtracting background ﬂuorescence from all samples,
untreated (no protein or heat) cellswere used to determine 100% viabil-
ity. To determine the number of cells protected from heat treatment by
α-crystallin, the following equation was used:
%viable ¼ % viablewithα‐crystallin−avg:% viablewithoutα‐crystallin
100−avg:% viablewithoutα‐crystallin
 100:
Results are reported as average ± standard deviation of at
least three independent experiments. Each experimental condition
was studied in triplicate. The p-values were calculated using a two-
tailed, Student's t-Test assuming equal variance.
2.5. Cellular oxidative stress assay
Treatment groups were assembled in the same manner as the
cellular heat stress assays described above. The only modiﬁcation from
the above assay is after α-crystallin treatment, cells were exposed to
37.5 μM H2O2 (Sigma) and incubated at 37 °C for 24 h. Cell viability
after this treatment was assessed using the calcein assay as above.
2.6. Chaperone-like activity measurements on
reduction-induced aggregation
Assays were performed similar to those previously described
[25,29,30]. Brieﬂy, 10 μM lysozyme (EMD Millipore, Philadelphia,
PA) was mixed with 1 mM DTT in the presence or absence of 10 μM
WT-αA, WT-αB, gC-αB, TAT-αB, or gC-αA. Reactions were monitored
for 1 h at 37 °C in a Cary 1E spectrophotometer ﬁtted with a Peltier
controlled sample carrier. Samples were continuously monitored for
light scattering at 360 nm for 60 min.
2.7. Toxicity assays
To assess the toxicity of α-crystallin preparations, HLE-B3 cells
were incubated for 1 h in the presence of 12.5 μg/ml, 37.5 μg/ml, or
125 μg/ml of each of ﬁve variants of α-crystallin prepared for this
study. After 1 h, media were replaced with α-crystallin-free media
and incubated overnight. 24 h post-α-crystallin exposure, cells were
harvested and viability was determined using the Live/Dead Viability/
Cytotoxicity Assay Kit (Life Technologies) as above. Assays were repeat-
ed in triplicate for each protein.
2.8. Chaperone-like activity measurements on heat-induced aggregation
CLA assays with the human aldose reductase AKR1B1 (HAR) heat-
induced aggregation assay have been described previously [27,28].
Brieﬂy, 2.5 μM recombinant HAR was mixed with 1 mM DTT in the
presence or absence of WT-αA, WT-αB, gC-αB, TAT-αB, or gC-αA (all
at 2.5 μM crystallin subunit concentration). Samples were incubated
for 30 min at 53 °C in a Cary 1E UV/vis spectrophotometer. Samples
were continuously monitored for light scattering at 360 nm for 60 min.
2.9. α-Crystallin conjugation to Alexa-Fluor-350 and Alexa-Fluor 488
α-Crystallins were conjugated with Alexa-Fluor-350 or Alexa-Fluor
488 ﬂuorophores according to the manufacturer's protocol (Life
Technologies). Concisely, α-crystallins in PBS were mixed with
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488 dye and incubated with mixing at 25 °C for 1 h. Alexa-Fluor dye-
labeled proteins were then passed over a kit-supplied desalting column
to remove unconjugated dye. Protein concentrations and percent
labeling were determined as recommended by the manufacturer.2.10. Microscopy analysis of α-crystallin
HLE-B3 cells were plated onto 35 mm glass bottom culture
dishes overnight to allow adherence. Cells with ~90% conﬂuence were
treated with 12.5 μg/ml of Alexa-Fluor-350 labeled α-crystallin for
1 h. The α-crystallin-supplemented medium was then replaced with
fresh media containing 37.5 μM H2O2 and cells incubated for 24 h.
Next, cellswere harvested andwashed twicewith PBS followed by incu-
bation in 1 ml of PBSwith 5 μM calcein AM solution at 25 °C for 20 min
in the dark. After incubation, cells were imagedusing aNikon 90imicro-
scope at 10× magniﬁcation. The Alexa-Fluor-350 labeled α-crystallin
detected by blue ﬂuorescence was converted to red in the images.2.11. Immunohistochemistry
Glass coverslips were placed into 12-well plates. HLE-B3 cells were
allowed to adhere to coverslips. After cells reached ~95% conﬂuence,
2 μg of Alexa-Fluor 488-labeled gC-αB were added to the well. After
72 h, coverslips were removed fromwells and rinsed in PBS. The cover-
slip was then placed in 100% methanol for 30 s, rinsed with 1× PBS for
30 s, and were then blocked with 2% w/v BSA in PBS for 30 min. After
blocking, α-crystallin antibody (a gift from Dr. Usha Andley, Washing-
ton University in St. Louis, MO) at 1/300 dilution in 2% BSA was added
for 20 min. The coverslip was then washed with PBS, again blocked
with 2% BSA for 30 min, then probed with a 1/500 dilution of goat
anti-rabbit 594 (Life Technologies) for 20 min. After another rinse
with PBS, the coverslip was mounted on a glass slide with DAPI withFig. 1. Localization of exogenousα-crystallin in HLE-B3 cells. HLE-B3 cells were treated with Al
withα-crystallin antibody followed by an Alexa-Fluor-594 secondary antibody (red). Cells wer
(A) co-localized with native α-crystallin (B) as seen when merged (C). Both protein were predVectaShield (Vector Laboratories, Burlingame, CA), and imaged using a
Nikon microscopy system.3. Results
3.1. Co-localization of native and recombinant α-crystallin taken up into
HLE-B3 cells
Previously we reported the uptake ofα-crystallin protein by HLE-B3
cells [25]. However, the localization of exogenous gC-αB was not deter-
mined. Using immunohistochemistry to detect α-crystallin in cells, we
found that Alexa-Fluor 488-labeled recombinant, exogenous proteins
co-localizewith the nativeα-crystallin in perinuclear regions; however,
it did not localize with native proteins at leading edges of cells (Fig. 1).
Moreover, exogenous α-crystallin formed punctate patterns in ~5% of
cells. This suggests that both the gC tag, as well as the cell uptakemech-
anism may affect the protein's trafﬁcking upon cell entry.3.2. Recombinant protein toxicity in HLE-B3 cells
A consequence of using recombinant proteins from E. coli is the
potential for toxic contaminants during puriﬁcation. As a ﬁrst step in
assessing the use of α-crystallins in a cell-based system, we tested
whether the treatment of HLE-B3 cells with recombinant proteins was
associated with toxicity. Treatment of HLE-B3 cells over a 10-fold
concentration range using ﬁve different α-crystallins was generally
not associated with any toxic effects (Fig. 2). Among the ﬁve protein
preparations tested, only WT-αA showed a statistically-signiﬁcant
reduction in cell viability (76.4% ± 12.4%, p b 0.01) but even in this
case, the reductionwas observed only in cells treated at the highest con-
centration (125 μg/ml). Additional puriﬁcation of α-crystallins over
polymyxin resin to remove endotoxin did not improve cell viability
(data not shown). An apparent increase in viability was observed inexa-Fluor 488-labeled gC-αB (green) for 72 h. Cells were ﬁxed with methanol and probed
emounted and stained with DAPI. Microscopy analysis of cells indicated exogenous gC-αB
ominately cytoplasmic and excluded from the DAPI (blue) stained nuclei (D).
Fig. 2. Toxicity of α-crystallins on HLE-B3 cells. HLE-B3 cells were treated with increasing concentrations (12.5 μg/ml, 37.5 μg/ml, and 125 μg/ml) of WT-αB, gC-αB, TAT-αB, WT-αA,
or gC-αA for 1 h. The α-crystallin proteins were removed and cells were incubated for 24 h. The viability of cells treated with α-crystallins was determined using Live/Dead Viability/
Cytotoxicity Assay Kit. Untreated HLE-B3 cells ﬂuorescence was set to 100% (control). Experiments were repeated in triplicate and reported at mean and std dev. ** = p b 0.01.
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er, there was no dose-dependency to deﬁne a trendwith either protein.3.3. Effect of cell penetration peptide on chaperone-like activity
To determine the functional impact of modifying α-crystallins by
the introduction of a cell penetration peptide (CPP), we conducted
chaperone-like activity assays using two distinctly different methods
to destabilize client proteins. In the ﬁrst case, we examined the chaper-
one activity ofα-crystallin proteins using heat-induced aggregation of a
client protein. As in our previous studies [28], we used human aldose re-
ductase (HAR) as a client protein to measure the ability of α-crystallin
to suppress formation of light scattering aggregates. WT-αB and WT-
αA almost completely prevented HAR aggregation under these condi-
tions (Fig. 3). The gC-αB protein reduced aggregation only modestly
(approximately 16%). Unexpectedly, TAT-αB and gC-αA appeared to
induce additional aggregation of the HAR client protein although no ap-
parent aggregation was observed when αA-crystallins were incubated
under these conditions in the absence of client protein (not shown).
To avoid complications associated with thermal destabilization of
modiﬁed α-crystallins at non-physiological temperatures, such as
with the behavior of TAT-αB and gC-αA described above, we conducted
additional chaperone-like activity assays at 37 °C. This was carried out
by measuring the suppression of DTT-reduction induced aggregation
of lysozyme as described by others [29,30]. Addition of the gC-cell


















Fig. 3. Analysis of chaperone-like protection of HAR against thermal aggregation. HAR
(2.5 μM) was combined with an equimolar amount of α-crystallin subunits, heated to
52 °C and monitored for protein aggregation by changes in light scattering at 360 nm.
No increase in light scattering indicates protection of HAR from aggregation.like activity ofαB-crystallin. Likewild type, gC-αB can almost complete-
ly suppress lysozyme aggregation (Fig. 4). In contrast, WT-αA was
somewhat less effective (prevented 61% aggregation) and gC-αA had
almost no CLA activity under these conditions. Similar to our observa-
tions with the heat induced aggregation assay, there was an increase
in lysozyme aggregation (114%) when chaperone-like assays were
carried out using TAT-αB.
3.4. α-Crystallin-mediated protection of HLE-B3 cells against
oxidative stress
Weused a hydrogen peroxide oxidative stressmodel in HLE-B3 cells
to test the ability of the variousα-crystallins to protect against oxidative
stress. Analysis of HLE-B3 cell viabilitywith concentrations of H2O2 from
0 to 300 μM indicated that amounts of 37.5 μM or greater induced apo-
ptosis as detected by DNA laddering and ﬂow cytometry (data not
shown). HLE-B3 cells were pretreated in media with 12.5 μg/ml recom-
binant α-crystallin protein for 1 h, cells were exposed to 37.5 μMH2O2
in media for 24 h. Using the calcein viability assay, the percent of cells
protected from oxidative stress induced apoptosis by each protein was
calculated (Fig. 5). All ﬁve recombinant α-crystallin proteins showed
statistically signiﬁcant protection of HLE-B3 cells. We observed that
gC-αB was particularly effective at protecting against peroxide-
induced apoptosis (cell viability was 147.0% ± 76.7%, p b 0.001 vs.
vehicle control). However, all α-crystallins examined afforded some
degree of protection against cell death, with WT-αB and its variants


















Fig. 4. Analysis of chaperone-like protection of lysozyme against DTT-induced aggrega-
tion. Lysozyme (10 μM)was combinedwith an equimolar amount ofα-crystallin subunits
and incubated for 1 h at 37 °C. Solutionsweremonitored for changes in light scattering by
measuring absorbance at 360 nm. No increase in light scattering indicates protection of
lysozyme from aggregation.
Fig. 5. Ability of recombinantα-crystallins to protect HLE-B3 cells against oxidative stress
was assayed by preloading the cells using 12.5 μg/ml of α-crystallin protein (WT-αB, gC-
αB, TAT-αB,WT-αA, or gC-αA) for 1 h prior to 24 h of exposure to 37.5 μMH2O2 followed
bya calcein viability assay. Results are reported as percentage of cells protected fromdeath
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binant HAR, puriﬁed from E. coli expression cultures [31], to control
for possible small molecular weight contaminants derived from high
density cultures of bacterial host cells. Such contaminants could
possibly affect the metric being studied, especially in cell-based assays.
In measurements of protection against oxidative stress, we used
170 μg HAR as a negative control for α-crystallins. Virtually no protec-
tive effect against oxidative stress was observed when HAR was
substituted for α-crystallin (19.1% ± 31.0%, p = 0.24).WT-αA
WT-αB3.5. α-Crystallin-mediated protection of HLE-B3 cells against heat stress
To further test the protective effects of α-crystallin against thermal
stress, we utilized a 45 °C heat-stress cell culture model of apoptosis.
Cells were pre-treated with recombinant α-crystallins, and were then
incubated at 45 °C for 1 h. Cell viability was measured 24 h later using
the calcein assay (Fig. 6). All three αB-crystallin proteins showed a sta-
tistically signiﬁcant protective effect when compared to cells receiving
no protein pretreatment. The strongest protective effect occurred with
WT-αB (34.0% ± 9.0%, p b 0.001), followed by gC-αB (32.9% ± 13.9%,
p b 0.001) and TAT-αB (24.6% ± 14.2%, p b 0.01).Fig. 6.α-Crystallin protection of HLE-B3 cells from heat stress. HLE-B3 cells were incubat-
ed for 1 h with 12.5 μg/ml of the indicated α-crystallins. Cells were then treated at 45 °C
for 1 h. After 24 h, calcein viability assay was used to determined cell survival.
* = p b 0.05, ** = p b 0.01, *** = p b 0.001.In contrast, the αA-crystallins failed to protect HLE-B3 cells from
the 45 °C heat induced apoptosis. Cells treated with both WT-αA and
gC-αA did not show a statistically signiﬁcant difference in cell viability
(4.9% ± 16.2%, p = 0.527 and−2.4% ± 15.3%, p = 0.740, respectively).
Similarly, essentially noprotectionwasobserved in cells treatedwithHAR
(negative control) (10.9% ± 10.3%, p = 0.084).3.6. Cell penetration of modiﬁed α-crystallins
α-Crystallins were labeled with an Alexa-Fluor 350 ﬂuorescent
probe to permit us tomonitor cellular uptake and persistence following
treatment with oxidative stress. We reasoned that this would allow us
to determine if there was a correlation between α-crystallin uptake
and cell viability following stress treatment. Indeed, uptake of each of
the different forms of α-crystallins was easily detected by ﬂuorescencegC-αA
gC-αB
TAT-αB
Fig. 7.Microscopy analysis of viable HLE-B3 cells treated withα-crystallin. 1 h pretreated
HLE-B3 cells with Alexa-Fluor 350 labeledWT-αA,WT-αB, gC-αA, or gC-αB were follow-
ed with a chemical stress of 37.5 μM H2O2 exposure for 24 h or a no H2O2 treatment
control. Viable cells were labeled and detected using calcein staining (green). Cells with
exogenousα-crystallins were detected by the presence of Alexa-Fluor 350 labeled protein
(red). Increased levels of α-crystallins localized with viable cells.
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Fluor-conjugated α-crystallins and those which stained positive for
calcein (green), the cell viability indicator (Fig. 7). Additionally, cells
treated with α-crystallin prior to exposure to hydrogen peroxide
treatment, displayed higher cell density compared to cells treated
with hydrogen peroxide alone (Fig. 7). These results are consistent
with the idea that the α-crystallins enter and protect cells from oxida-
tive stress induced apoptosis.
4. Discussion
In this study, we have shown that recombinant α-crystallin can
enter HLE-B3 cells and a substantial amount of it may co-localize with
endogenous α-crystallins. These results provide evidence that human
α-crystallins produced in a bacterial expression host and puriﬁed by
conventional protein separation media can be introduced to human-
derived cells without toxic effects associated with the protein or
contaminating by-products. Additionally, cells treated with exogenous
α-crystallin proteins had reduced levels of apoptosis when stressed
with oxidative or thermal insults. This uptake of α-crystallin (Fig. 7),
which occurred rapidly, correlated with protection. In the case of gC-
αB, we previously found that protein uptake could be achieved within
60 min of exposure to cells [25]. Of note was the ﬁnding that even α-
crystallins without cell penetration tags were able to prevent thermal
and oxidative stress. Since excess α-crystallins are removed from the
media prior to cells being stressed, the observation that these proteins
are still protective suggests the possibility that a slower but still effective
uptake mechanism is occurring. Another possibility is thatα-crystallins
may act through an extracellular mechanism to protect cells. This latter
notion seems plausible in light of previous reports that sHSP may be
associated with membranes and may be secreted from the cell [32].
We initially expected that the protective potential of α-crystallins
would correlate with their in vitro chaperone-like capabilities revealed
in client protein-binding assays. For example, wild type αA-crystallin,
which has a strong CLA proﬁle, was relatively ineffective in protecting
against heat- and oxidative stress-induced cell death. Differences in
assay conditions between in vitro and in vivo assays could explain the
apparent discordancy between CLA and cellular protection. First, our
chaperone-like activity assays using the heat-induced HAR aggregation
assay, indicated that WT-αA and WT-αB have similarly strong chaper-
one activity while gC-αB and TAT-αB had minimal chaperone activity.
These in vitro CLA assay results differed widely from the cell culture
model results; however, the conditions for the two assays are quite dif-
ferent as the CLA assay was conducted at 52 °C, a temperature at which
αB-crystallin has been shown to be more structurally unstable [33],
while the cell culturemodel heat stress occurred at 45 °C. Previous stud-
ies showed that αB-crystallin undergoes heat-induced structural alter-
ations starting at 45 °C, while αA-crystallin retains its structure to
temperatures up to 55 °C [33]. It is possible that the addition of CPP
tags to αB-crystallin further destabilizes the protein structure such
that gC-αB and TAT-αB had substantially reduced chaperone-like activ-
ity against 52 °C heat-induced aggregation of HAR in vitro. Similarly,
TAT-αB did not prevent aggregation in lysozyme DTT-induced in vitro
assays, but showed a protective effect in the cell based oxidative stress
model. The other α-crystallin proteins were roughly consistent
between in vitro and cell based assay of oxidative stress. Furthermore,
our results are consistent with previous studies in which αB-crystallin
showed a stronger ability to protect against DTT-induced insulin aggre-
gation at 35 °C thanαA-crystallin. This difference disappeared at higher
temperatures due to the relative instability of αB-crystallin to elevated
temperatures [33].
In our chemical-induced aggregation assay, WT-αB and gC-αB
exhibited the strongest chaperone-like activity. In the tissue culture
model, WT-αB and gC-αB also showed the strongest ability to protect
against oxidative-stress induced apoptosis. Unexpectedly, TAT-αB,
which was ineffective in the lysozyme-based chaperone assays,provided signiﬁcant protection to HLE-B3 cells exposed to hydrogen
peroxide challenge. The reason for this divergence is unclear at this
time, but may relate to translocation to subcellular compartments as
reported by others [34].
All of the various forms of α-crystallin tested (WT-αB, WT-αA, gC-
αB, TAT-αB, gC-αA) had protective effects on HLE-B3 cells against
oxidative stress, and a subset of these (WT-αB, gC-αB, TAT-αB) also
had protective effects against heat stress. αB-crystallin modiﬁed with
a gC cell penetration peptide at the N-terminus (gC-αB) stood out as
the most promising of the α-crystallins tested in this study. The gC-αB
had strong protective effects against both heat and oxidative stress,
was free of measurable toxic effects on the HLE-B3 cells, and appeared
to distribute well throughout the cells as shown by immunoﬂuores-
cence and Alexa-Fluor-tracking by ﬂuorescence microscopy (Fig. 1).
Others have shown that peptides derived from α-crystallin (mini-
chaperone) can also prevent protein aggregation in vitro and protect
cells from apoptosis [35,36].
In addition to playing a key role as a structural lens protein, it is now
becoming evident that α-crystallins may contribute to protection from
many diseases in the eye, including cataract, retinitis pigmentosa,
and macular degeneration [35,37,38]. Protective roles for α-crystallin
have been identiﬁed outside the eye as well, in conditions such as
Alzheimer's disease, prion disease, autoimmune encephalomyelitis
[39], and various cardiomyopathies. Prior studies to investigate the
protective effects of α-crystallin by altering intracellular levels of the
protein have relied on cell transfection with α-crystallin expression
plasmids, as well as α-crystallin knock-out mice [40]. However, the
possibility of enriching cells with recombinant α-crystallin protein
supplied post-translationally received only limited study [41].
5. Conclusions
The ability to modify α-crystallins for enhanced cellular uptake lays
the foundation for their use as therapeutic proteins against a wide array
of diseases.
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